Marc Hafner
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Advanced Breast Cancer Therapies, Computational Drug Discovery Methods, Fibroblast Growth Factor Research, Gene Regulatory Network Analysis
Most-Cited Works
- → Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs(2016)713 cited
- → The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations(2017)436 cited
- → L1000CDS2: LINCS L1000 characteristic direction signatures search engine(2016)373 cited
- → LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures(2014)338 cited
- → Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity(2019)246 cited
- → Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its Mobility(2019)218 cited
- → Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patients(2021)176 cited
- → An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance(2023)174 cited
- → Fractional killing arises from cell‐to‐cell variability in overcoming a caspase activity threshold(2015)145 cited
- → A Multi-center Study on the Reproducibility of Drug-Response Assays in Mammalian Cell Lines(2019)140 cited